CFO
UTHR icon

Callan Family Office’s United Therapeutics UTHR Stock Holding History

Callan Family Office’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$997K Buy
3,468
+2,500
+258% +$718K 0.03% 404
2025
Q1 		$298K Buy
968
+50
+5% +$15.4K 0.02% 428
2024
Q4 		$324K Buy
+918
New +$324K 0.02% 465